BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86% Market Closed
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

BRAIN Biotech AG
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BRAIN Biotech AG
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Cash from Operating Activities
-€1.8m
CAGR 3-Years
15%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Cash from Operating Activities
€588.8m
CAGR 3-Years
-19%
CAGR 5-Years
8%
CAGR 10-Years
1%
Evonik Industries AG
XETRA:EVK
Cash from Operating Activities
€2B
CAGR 3-Years
-2%
CAGR 5-Years
5%
CAGR 10-Years
9%
Covestro AG
XETRA:1COV
Cash from Operating Activities
€635m
CAGR 3-Years
-34%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Cash from Operating Activities
€72.7m
CAGR 3-Years
14%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Cash from Operating Activities
€851.9m
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

BRAIN Biotech AG
Glance View

Market Cap
75.2m EUR
Industry
Chemicals

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

BNN Intrinsic Value
5.17 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is BRAIN Biotech AG's Cash from Operating Activities?
Cash from Operating Activities
-1.8m EUR

Based on the financial report for Jun 30, 2024, BRAIN Biotech AG's Cash from Operating Activities amounts to -1.8m EUR.

What is BRAIN Biotech AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-2%

Over the last year, the Cash from Operating Activities growth was 63%. The average annual Cash from Operating Activities growth rates for BRAIN Biotech AG have been 15% over the past three years , -2% over the past five years .

Back to Top